{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:35:47Z","timestamp":1794353747992,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE 2701\/16-1"],"award-info":[{"award-number":["HE 2701\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oversea Study Program of Guangzhou Elite Project"},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The gene encoding the RNA-binding motif protein 47 (RBM47) is highly expressed in epithelial cells and its down-regulation is characteristic for many types of cancer, among them colorectal cancer (CRC). However, the underlying mechanisms for this differential expression of\n                    <jats:italic>RBM47<\/jats:italic>\n                    and its functional consequences during CRC progression have remained unknown. Here we found that\n                    <jats:italic>RBM47<\/jats:italic>\n                    expression progressively decreases during CRC progression and is associated with poor prognosis and the metastatic CRC subtypes CMS4 and CRIS-B. In mice and humans\n                    <jats:italic>RBM47<\/jats:italic>\n                    expression was highest in endoderm-derived tissues. The expression of forkhead box A1 (\n                    <jats:italic>FOXA1)<\/jats:italic>\n                    , a transcription factor essential for the development of endoderm-derived epithelial tissues, showed a positive correlation with\n                    <jats:italic>RBM47<\/jats:italic>\n                    expression in human tissues, as well as in primary CRCs and derived cell lines. Like RBM47,\n                    <jats:italic>FOXA1<\/jats:italic>\n                    showed a down-regulation during CRC progression that is associated with poor prognosis and CMS4\/CRIS-B. Ectopic FOXA1 induced\n                    <jats:italic>RBM47<\/jats:italic>\n                    via directly binding to FOXA1 binding sites within the\n                    <jats:italic>RBM47<\/jats:italic>\n                    promoter region. Up-regulation of\n                    <jats:italic>RBM47<\/jats:italic>\n                    was necessary for FOXA1-mediated mesenchymal-to-epithelial transition (MET) and inhibition of CRC cell migration and invasion.\n                    <jats:italic>RBM47<\/jats:italic>\n                    expression was silenced by CpG methylation in mesenchymal-like CRC cell lines. Moreover, epigenetic silencing of\n                    <jats:italic>RBM47<\/jats:italic>\n                    in primary CRCs was associated with liver metastases. Therefore, the down-regulation of\n                    <jats:italic>RBM47<\/jats:italic>\n                    is presumably initially mediated by loss of\n                    <jats:italic>FOXA1<\/jats:italic>\n                    expression and subsequently fixed by CpG methylation of the\n                    <jats:italic>RBM47<\/jats:italic>\n                    promoter. This down-regulation of\n                    <jats:italic>RBM47<\/jats:italic>\n                    facilitates EMT and thereby promotes CRC metastasis. Finally, our results show that CpG hypermethylation of the\n                    <jats:italic>RBM47<\/jats:italic>\n                    promoter represents a potential biomarker for metastatic CRC.\n                  <\/jats:p>","DOI":"10.1186\/s43556-025-00382-4","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:23:51Z","timestamp":1764753831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Down-regulation of RBM47 due to diminished activation by forkhead box A1 (FOXA1) and silencing by CpG methylation is associated with epithelial-mesenchymal transition and metastasis of colorectal cancer"],"prefix":"10.1186","volume":"6","author":[{"given":"Matjaz","family":"Rokavec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-4406","authenticated-orcid":false,"given":"Heiko","family":"Hermeking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"382_CR1","unstructured":"GLOBOCAN Global Cancer Observatory (GCO). https:\/\/gco.iarc.fr (accessed in August 2025)."},{"issue":"1","key":"382_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cam4.2673","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med. 2020;9(1):361\u201373. https:\/\/doi.org\/10.1002\/cam4.2673.","journal-title":"Cancer Med"},{"issue":"12","key":"382_CR3","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1007\/s11010-021-04256-5","volume":"476","author":"PKM Shivalingappa","year":"2021","unstructured":"Shivalingappa PKM, Sharma V, Shiras A, Bapat SA. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer. Mol Cell Biochem. 2021;476(12):4493\u2013505. https:\/\/doi.org\/10.1007\/s11010-021-04256-5.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"382_CR4","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1038\/s41598-017-04234-2","volume":"7","author":"M Rokavec","year":"2017","unstructured":"Rokavec M, Kaller M, Horst D, Hermeking H. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Sci Rep. 2017;7(1):4687. https:\/\/doi.org\/10.1038\/s41598-017-04234-2.","journal-title":"Sci Rep"},{"issue":"38","key":"382_CR5","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1038\/onc.2016.35","volume":"35","author":"T Sakurai","year":"2016","unstructured":"Sakurai T, Isogaya K, Sakai S, Morikawa M, Morishita Y, Ehata S, et al. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma. Oncogene. 2016;35(38):5000\u20139. https:\/\/doi.org\/10.1038\/onc.2016.35.","journal-title":"Oncogene"},{"key":"382_CR6","doi-asserted-by":"publisher","unstructured":"Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A et al. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. Elife. 2014;3. https:\/\/doi.org\/10.7554\/eLife.02734.","DOI":"10.7554\/eLife.02734"},{"key":"382_CR7","doi-asserted-by":"publisher","unstructured":"Soleymanjahi S, Blanc V, Molitor EA, Alvarado DM, Xie Y, Gazit V et al. RBM47 regulates intestinal injury and tumorigenesis by modifying proliferation, oxidative response, and inflammatory pathways. JCI Insight. 2023;8(9). https:\/\/doi.org\/10.1172\/jci.insight.161118","DOI":"10.1172\/jci.insight.161118"},{"issue":"3","key":"382_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49(3):361\u201374. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.010.","journal-title":"Dev Cell"},{"issue":"11","key":"382_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/MCB.00019-16","volume":"36","author":"Y Yang","year":"2016","unstructured":"Yang Y, Park JW, Bebee TW, Warzecha CC, Guo Y, Shang X, et al. Determination of a comprehensive alternative splicing regulatory network and combinatorial regulation by key factors during the epithelial-to-mesenchymal transition. Mol Cell Biol. 2016;36(11):1704\u201319. https:\/\/doi.org\/10.1128\/MCB.00019-16.","journal-title":"Mol Cell Biol"},{"issue":"38","key":"382_CR10","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1038\/s41388-019-0892-5","volume":"38","author":"YE Kim","year":"2019","unstructured":"Kim YE, Won M, Lee SG, Park C, Song CH, Kim KK. RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition. Oncogene. 2019;38(38):6521\u201336. https:\/\/doi.org\/10.1038\/s41388-019-0892-5.","journal-title":"Oncogene"},{"issue":"2","key":"382_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbcan.2016.04.001","volume":"1865","author":"A Kazanets","year":"2016","unstructured":"Kazanets A, Shorstova T, Hilmi K, Marques M, Witcher M. Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential. Biochim Biophys Acta. 2016;1865(2):275\u201388. https:\/\/doi.org\/10.1016\/j.bbcan.2016.04.001.","journal-title":"Biochim Biophys Acta"},{"issue":"19\u201320","key":"382_CR12","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00018-006-6095-6","volume":"63","author":"JR Friedman","year":"2006","unstructured":"Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci. 2006;63(19\u201320):2317\u201328. https:\/\/doi.org\/10.1007\/s00018-006-6095-6.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"382_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cr.2010.126","volume":"21","author":"Y Tang","year":"2011","unstructured":"Tang Y, Shu G, Yuan X, Jing N, Song J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res. 2011;21(2):316\u201326. https:\/\/doi.org\/10.1038\/cr.2010.126.","journal-title":"Cell Res"},{"issue":"5","key":"382_CR14","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1158\/0008-5472.CAN-09-2979","volume":"70","author":"Y Song","year":"2010","unstructured":"Song Y, Washington MK, Crawford HC. Loss of FOXA1\/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 2010;70(5):2115\u201325. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2979.","journal-title":"Cancer Res"},{"issue":"11","key":"382_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007109","volume":"13","author":"S Jagle","year":"2017","unstructured":"Jagle S, Busch H, Freihen V, Beyes S, Schrempp M, Boerries M, et al. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells. PLoS Genet. 2017;13(11):e1007109. https:\/\/doi.org\/10.1371\/journal.pgen.1007109.","journal-title":"PLoS Genet"},{"key":"382_CR16","doi-asserted-by":"publisher","unstructured":"Lazar SB, Pongor L, Li XL, Grammatikakis I, Muys BR, Dangelmaier EA et al. Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells. Mol Cell Biol. 2020;40(21). https:\/\/doi.org\/10.1128\/MCB.00224-20","DOI":"10.1128\/MCB.00224-20"},{"issue":"11","key":"382_CR17","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136. https:\/\/doi.org\/10.1038\/nm.3967.","journal-title":"Nat Med"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.1038\/ncomms15107","volume":"8","author":"C Isella","year":"2017","unstructured":"Isella C, Brundu F, Bellomo SE, Galimi F, Zanella E, Porporato R, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017;8:15107. https:\/\/doi.org\/10.1038\/ncomms15107.","journal-title":"Nat Commun"},{"issue":"8","key":"382_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.15252\/embr.201438450","volume":"15","author":"N Fossat","year":"2014","unstructured":"Fossat N, Tourle K, Radziewic T, Barratt K, Liebhold D, Studdert JB, et al. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. EMBO Rep. 2014;15(8):903\u201310. https:\/\/doi.org\/10.15252\/embr.201438450.","journal-title":"EMBO Rep"},{"issue":"1","key":"382_CR20","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1038\/s41598-025-87660-x","volume":"15","author":"S Shinji","year":"2025","unstructured":"Shinji S, Ogawa Y, Yamada T, Matsuda A, Uehara K, Yokoyama Y, et al. Morphological and functional analysis of colorectal cancer cell lines in 2D and 3D culture models. Sci Rep. 2025;15(1):3047. https:\/\/doi.org\/10.1038\/s41598-025-87660-x.","journal-title":"Sci Rep"},{"issue":"4","key":"382_CR21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/JCI73531","volume":"124","author":"M Rokavec","year":"2014","unstructured":"Rokavec M, Oner MG, Li H, Jackstadt R, Jiang L, Lodygin D, et al. IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest. 2014;124(4):1853\u201367. https:\/\/doi.org\/10.1172\/JCI73531.","journal-title":"J Clin Invest"},{"issue":"6","key":"382_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","volume":"132","author":"M Lupien","year":"2008","unstructured":"Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132(6):958\u201370. https:\/\/doi.org\/10.1016\/j.cell.2008.01.018.","journal-title":"Cell"},{"issue":"5","key":"382_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg AP, Koldobskiy MA, Gondor A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284\u201399. https:\/\/doi.org\/10.1038\/nrg.2016.13.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"382_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1078-0432.CCR-12-17031078-0432.CCR-12-1703[pii]","volume":"19","author":"H Siemens","year":"2013","unstructured":"Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T, et al. Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and beta-Catenin Predicts Distant Metastasis of Colon Cancer. Clin Cancer Res. 2013;19(3):710\u201320. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1703.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"382_CR25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1365-2559.2011.04126.x","volume":"60","author":"J Neumann","year":"2012","unstructured":"Neumann J, Horst D, Kriegl L, Maatz S, Engel J, Jung A, et al. A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer. Histopathology. 2012;60(3):416\u201326. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04126.x.","journal-title":"Histopathology"},{"issue":"4","key":"382_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1101\/gr.111534.110","volume":"21","author":"AA Serandour","year":"2011","unstructured":"Serandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res. 2011;21(4):555\u201365. https:\/\/doi.org\/10.1101\/gr.111534.110.","journal-title":"Genome Res"},{"issue":"1","key":"382_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13072-022-00444-9","volume":"15","author":"RB Lemma","year":"2022","unstructured":"Lemma RB, Fleischer T, Martinsen E, Ledsaak M, Kristensen V, Eskeland R, et al. Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers. Epigenetics Chromatin. 2022;15(1):13. https:\/\/doi.org\/10.1186\/s13072-022-00444-9.","journal-title":"Epigenetics Chromatin"},{"issue":"17","key":"382_CR28","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1093\/nar\/gkw498","volume":"44","author":"YA Yang","year":"2016","unstructured":"Yang YA, Zhao JC, Fong KW, Kim J, Li S, Song C, et al. FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function. Nucleic Acids Res. 2016;44(17):8153\u201364. https:\/\/doi.org\/10.1093\/nar\/gkw498.","journal-title":"Nucleic Acids Res"},{"issue":"5929","key":"382_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135. https:\/\/doi.org\/10.1126\/science.1170116.","journal-title":"Science"},{"key":"382_CR30","doi-asserted-by":"publisher","unstructured":"Vaidya H, Jelinek J, Issa JJ. DNA Methylation, Aging, and Cancer. Epigenomes. 2025;9(2). https:\/\/doi.org\/10.3390\/epigenomes9020018.","DOI":"10.3390\/epigenomes9020018"},{"key":"382_CR31","doi-asserted-by":"publisher","unstructured":"Wang Y, Wang C, Zhong R, Wang L, Sun L. Research progress of DNA methylation in colorectal cancer (Review). Mol Med Rep. 2024;30(3). https:\/\/doi.org\/10.3892\/mmr.2024.13278","DOI":"10.3892\/mmr.2024.13278"},{"issue":"4","key":"382_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/1541-7786.MCR-09-0496","volume":"8","author":"E Foran","year":"2010","unstructured":"Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, et al. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res. 2010;8(4):471\u201381. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0496.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"382_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","volume":"8","author":"X Xia","year":"2020","unstructured":"Xia X, Wu WKK, Wong SH, Liu D, Kwong TNY, Nakatsu G, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 2020;8(1):108. https:\/\/doi.org\/10.1186\/s40168-020-00847-4.","journal-title":"Microbiome"},{"key":"382_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gene.2017.11.023","volume":"642","author":"M Lin","year":"2018","unstructured":"Lin M, Pan J, Chen Q, Xu Z, Lin X, Shi C. Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells. Gene. 2018;642:145\u201351. https:\/\/doi.org\/10.1016\/j.gene.2017.11.023.","journal-title":"Gene"},{"issue":"13","key":"382_CR35","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1242\/dev.01176","volume":"131","author":"D Sinner","year":"2004","unstructured":"Sinner D, Rankin S, Lee M, Zorn AM. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development. 2004;131(13):3069\u201380. https:\/\/doi.org\/10.1242\/dev.01176.","journal-title":"Development"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.suronc.2020.02.011","volume":"34","author":"DJ Shen","year":"2020","unstructured":"Shen DJ, Jiang YH, Li JQ, Xu LW, Tao KY. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt\/beta-catentin signaling. Surg Oncol. 2020;34:31\u20139. https:\/\/doi.org\/10.1016\/j.suronc.2020.02.011.","journal-title":"Surg Oncol"},{"issue":"9","key":"382_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"382_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2017.04.017","volume":"153","author":"H Li","year":"2017","unstructured":"Li H, Rokavec M, Jiang L, Horst D, Hermeking H. Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells. Gastroenterology. 2017;153(2):505\u201320. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.017.","journal-title":"Gastroenterology"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00382-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:23:52Z","timestamp":1764753832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00382-4","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FFPE colon cancer samples were collected at the Ludwig-Maximilians-University of Munich (LMU) between 1994 and 2005. Follow-up data were recorded by the Munich\u00a0tumor registry. The patient samples were subjected to irreversible anonymization. Studies with irreversible anonymization of patient samples were exempted from ethical approval by the ethics committee of the Medical Faculty of the LMU on November 8, 2007. All analyses were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Since the patient samples analyzed in Fig.\u00a0\n                      \n                      e-g had been subjected to irreversible anonymization, an informed consent was not necessary according to the LMU Medical Faculty Ethics Committee. Data from all other patient samples analyzed in this study was obtained from public repositories.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}